Bioventus (BVS) Other Non Operating Income (2020 - 2026)
Bioventus' (BVS) quarterly Other Non Operating Income came in at $928000.0 in Q2 2026, up 265.42% on a YoY basis from $253955.1 in Q2 2025, and down 7.2% quarter-over-quarter from $1.0 million in Q1 2026.
Analysis
Bioventus (BVS) Other Non Operating Income (2020 - 2026) Analysis & Trends
Bioventus (BVS) has reported Other Non Operating Income for 7 consecutive years, with $928000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non Operating Income rose 265.42% year-over-year to $928000.0; the trailing twelve-month figure through Jun 2026 stood at $1.1 million (up 109.07% YoY), and the FY2025 full-year result was -$1.5 million, down 188.39% from the prior year.
- Other Non Operating Income eased to $928000.0 in Q2 2026 per BVS's latest filing, from $1.0 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $1.6 million in Q2 2023 and bottomed at -$9.4 million in Q4 2022.
- Historically, Other Non Operating Income has averaged -$392611.1 across 5 years, with a median of -$89000.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: Other Non Operating Income jumped 337.47% in 2023, then tumbled 1133.33% in 2025.
- Over 5 years, Other Non Operating Income stood at -$9.4 million in 2022, then surged by 107.53% to $709000.0 in 2023, then surged by 75.04% to $1.2 million in 2024, then sank by 102.98% to -$37000.0 in 2025, then jumped by 2608.11% to $928000.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $928000.0, $1.0 million, and -$37000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Bioventus | 923.70 Mn | 894.24 Mn | 105.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 928,000.00 |
| Mar 28, 2026 | 1.00 Mn |
| Dec 31, 2025 | -37,000.00 |
| Sep 27, 2025 | -785,000.00 |
| Jun 28, 2025 | -561,000.00 |
| Mar 29, 2025 | -777,000.00 |
| Dec 31, 2024 | 1.24 Mn |
| Sep 28, 2024 | 626,000.00 |
| Jun 29, 2024 | -159,000.00 |
| Mar 30, 2024 | -63,000.00 |
| Dec 31, 2023 | 709,000.00 |
| Sep 30, 2023 | -494,000.00 |
| Jul 1, 2023 | -513,000.00 |
| Apr 1, 2023 | 1.59 Mn |
| Dec 31, 2022 | -9.41 Mn |
| Oct 1, 2022 | -115,000.00 |
| Jul 2, 2022 | -604,000.00 |
| Apr 2, 2022 | 363,000.00 |
| Dec 31, 2021 | 1.36 Mn |
| Oct 2, 2021 | -757,000.00 |